Targeting a coronavirus O
n the afternoon of March 12, Bruno Miguel da Cruz Godinho, PhD, sent an email to his colleagues in the Khvorova lab with the subject line “RNAi versus coronavirus.” The email didn’t contain much: the lab’s most advanced chemistries at the time and a link to a paper published only a few days earlier in Nature identifying two potential genetic targets that might slow SARS-CoV-2, the coronavirus that causes COVID-19. Anastasia Khvorova PhD, had a simple, four-word reply for her 25-person lab: “We can do it.”
PHOTO COURTESY OF THE CENTERS FOR DISEASE CONTROL AND PREVENTION
14 | 2020
